1. Ocular Nerve Growth Factor Administration Modulates Brain-derived Neurotrophic Factor Signaling in Prefrontal Cortex of Healthy and Diabetic Rats
- Author
-
Sandra Moreno, Paola Tirassa, Sara De Nicolò, Marco Fiore, Valentina Carito, Pamela Rosso, and Angela Iannitelli
- Subjects
Male ,0301 basic medicine ,medicine.medical_specialty ,Submandibular Gland ,Prefrontal Cortex ,Neural Cell Adhesion Molecule L1 ,Brain damage ,Tropomyosin receptor kinase B ,Neuroprotection ,Streptozocin ,Diabetes Mellitus, Experimental ,Rats, Sprague-Dawley ,03 medical and health sciences ,0302 clinical medicine ,Neurotrophic factors ,Physiology (medical) ,Internal medicine ,Nerve Growth Factor ,Reaction Time ,medicine ,Animals ,Pharmacology (medical) ,Depression ,Diabetes ,NGF eyedrops ,p75NTR ,TrkB ,Prefrontal cortex ,Pharmacology ,Brain-derived neurotrophic factor ,Depressive Disorder ,Caspase 3 ,Glutamate Decarboxylase ,business.industry ,Brain-Derived Neurotrophic Factor ,Body Weight ,Original Articles ,Rats ,Disease Models, Animal ,Psychiatry and Mental health ,030104 developmental biology ,Nerve growth factor ,Endocrinology ,nervous system ,Phosphopyruvate Hydratase ,Forebrain ,Sialic Acids ,medicine.symptom ,business ,030217 neurology & neurosurgery ,Signal Transduction - Abstract
SummaryAims Nerve growth factor (NGF) eyedrops (ed-NGF) activate brain neurons, stimulate growth factors, including brain-derived neurotrophic factor (BDNF), and exert neuroprotection in the forebrain of streptozotocin-induced diabetic rats (STZ rats). In this study, the effects of ed-NGF on BDNF signaling in the prefrontal cortex (PFC) were explored in healthy and STZ-diabetic rats, in which cortical neuronal and axonal loss, and altered circulating BDNF associated with depressive phenotype are also described. Methods STZ and healthy (CTR) adult rats received ed-NGF twice a day for 2 weeks. Depressive phenotype was identified by force swimming test (FST). Proteins extracted from PFC were processed for ELISA and Western blot analyses to measure the expression of BDNF, proBDNF, and their receptors and intracellular signals. Results ed-NGF treatment modulates BDNF pathway in PFC and normalizes the STZ-induced BDNF alterations by stimulating TRK-mediated survival mechanism. A decreased latency in FST was also found in STZ rats, while no change was observed comparing CTR + NGF and STZ + NGF with CTR. Conclusion The present data confirm the capacity of ed-NGF treatment to affect brain neurons and lead to brain damage recovery by activating protective and remodeling pathways triggered by BDNF. We suggest that the ed-NGF-induced changes in BDNF signaling might influence the manifestation of depressive phenotype in diabetic rats.
- Published
- 2017
- Full Text
- View/download PDF